Pre-clinical efficacy of combined therapy with novel β-catenin antagonist BC2059 and histone deacetylase inhibitor against AML cells (Q35685058)
Jump to navigation
Jump to search
scientific article published on 8 December 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Pre-clinical efficacy of combined therapy with novel β-catenin antagonist BC2059 and histone deacetylase inhibitor against AML cells |
scientific article published on 8 December 2014 |
Statements
Pre-clinical efficacy of combined therapy with novel β-catenin antagonist BC2059 and histone deacetylase inhibitor against AML cells (English)
W Fiskus
S Sharma
S Saha
B Shah
S G T Devaraj
B Sun
S Horrigan
C Leveque
Y Zu
8 December 2014
1 reference
1 reference